U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003347) titled 'Study to Investigate the Efficacy and Safety of SC0023, in Adults With Refractory or Unexplained Chronic Cough' on May 14.
Brief Summary: This is a randomized, double-blind, placebo controlled cross-over study to investigate the efficacy and safety of SC0023 (an oral spray of magnesium based alkaline hypertonic divalent salt) in adults with refractory or unexplained chronic cough over 14 days.
Approximately 20 participants being enrolled and randomized into the study.
Study Start Date: Dec. 19, 2024
Study Type: INTERVENTIONAL
Condition:
Chronic Cough
Intervention:
DEVICE: oral spray of MgCl2
Magnesium Salt Oral Spray Device
...